Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortShort-course malaria prevention and treatment for travellers.The most-used malaria treatment.
Body systemAntiparasiticsAntiparasitics
Drug classOther antimalarialsArtemisinins
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesMalaria prevention in travellers, Treatment of uncomplicated falciparum malariaUncomplicated falciparum malaria, Malaria in children
How it worksStops malaria parasites using their energy supply and DNA building.One drug knocks parasites down fast; the other finishes them off.
Starts workingHours—
Half-life2–3 days (atovaquone)Artemether ~2 hours; lumefantrine 3–6 days
Typical adult dose1 adult tablet (250/100 mg) once a day for prevention.6 doses over 3 days (4 tablets each, at 0, 8, 24, 36, 48 and 60 hours), with fatty food or milk.
FormsTabletTablet, Dispersible tablet
Common side effectsHeadache, Nausea, Abdominal pain, Mouth ulcersHeadache, Dizziness, Loss of appetite, Weakness
Serious side effectsLiver injury (rare), Severe skin reactionsQT prolongation, Delayed anaemia (rare)
Don't take ifSevere kidney impairment (creatinine clearance under 30 mL/min) for prevention; Taking rifampicin—
AlcoholUsually no problem in moderation. No direct interaction.—
PregnancyUse with cautionLimited data; avoid unless necessary.Generally considered safeWHO recommends it in all trimesters since 2022.
BreastfeedingUse with cautionLimited data; avoid if the infant weighs under 5 kg.—
In use since—1999
Brand namesUnited States: MalaroneUnited Kingdom: MalaroneIndia: MalaroneUnited States: CoartemUnited Kingdom: RiametIndia: Lumerax, Falcynate-LF
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeP01BB51P01BF01

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker